Glioom kliinilised uuringud osariigis Ohio
18 uuringut haiguse Glioom jaoks otsivad osalejaid osariigis Ohio.
Linnad osariigis Ohio
Ametlik uuringutekst (inglise keeles)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- ja veel 3
VärbamineFaas 1/2
12 Months – 21 Years · Kõik sood · Uuendatud 1. okt 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Cleveland Clinic Taussig Cancer Center, Cleveland
- Ohio State University, Columbus
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineFaas 2
12 Months – 39 Years · Kõik sood · Uuendatud 21. sept 2026 · NCT06838676Development of MRF for Characterization of Brain Tumors After Radiotherapy
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
VärbamineTerved vabatahtlikud oodatud
Vanused 18–60 · Kõik sood · Uuendatud 15. sept 2026 · NCT06101069Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineVaatlusuuring
12 Months – 39 Years · Kõik sood · Uuendatud 8. sept 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineFaas 2
Vanused 12–39 · Kõik sood · Uuendatud 1. sept 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Cleveland Clinic, Cleveland
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. aug 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineFaas 2
Vanused 3–39 · Kõik sood · Uuendatud 24. aug 2026 · NCT05096481Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 6. aug 2026 · NCT05565118A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nationwide Children's Hospital, Colombus
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
VärbamineFaas 2
Vanused 8 ja vanemad · Kõik sood · Uuendatud 27. juuli 2026 · NCT05503797Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Ohio State University Medical Center, Columbus
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 21. juuli 2026 · NCT06910306Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineFaas 1/2
Vanused 4–39 · Kõik sood · Uuendatud 20. juuli 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineVarajane 1. faasTerved vabatahtlikud oodatud
Vanused 1–21 · Kõik sood · Uuendatud 29. juuni 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineFaas 2
12 Months – 39 Years · Kõik sood · Uuendatud 29. mai 2026 · NCT05843253Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
- Ohio State University Comprehensive Cancer Center, Columbus
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. mai 2026 · NCT06964737Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Ohio State University Comprehensive Cancer Center, Columbus
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. apr 2026 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
VärbamineVarajane 1. faas
Kuni 21 aastane · Kõik sood · Uuendatud 18. märts 2026 · NCT04655404Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
- Nationwide Children's Hospital, Columbus
VärbamineFaas 1
12 Months – 39 Years · Kõik sood · Uuendatud 13. mai 2025 · NCT04254419Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.